Peptide Labs: 8 Kovera certificates.
The lab's record shows 8 certificates printed for Peptide Labs, analysed between 30 May 2026 and 30 May 2026, covering 8 products. Median HPLC purity is 99.57%. Kovera graded 8 as a pass and 0 as a fail.
What the record shows
RETRIEVED 2 AUGUST 2026None of the 8 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 6 measured more than 110% of the label, which Kovera does not grade as a fail.
Kovera revised 5 of these certificates after first publication, under the same report number: KVR-2026-D86FB9 (revised by the lab 2026-05-31, figures unchanged); KVR-2026-B04D4E (revised by the lab 2026-05-31, figures unchanged); KVR-2026-AD8EE3 (revised by the lab 2026-05-31, figures unchanged); KVR-2026-912564 (revised by the lab 2026-05-31, figures unchanged); KVR-2026-0DFF88 (revised by the lab 2026-05-31, figures unchanged). Why that matters is in our revisions analysis.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
8 AS PRINTEDEvery certificate
NEWEST FIRST · 8 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-D86FB9 | BPC-157/TB-500 | BB04154 | 99.934% | 112.8%11.28 of 10 mg | 30 May 2026 | PASSover 110% of labelrevised by the lab 2026-05-31, figures unchanged | Kovera ↗our verifier → |
| KVR-2026-C94812 | Tesamorelin | TSM4986 | 99.49% | 107.3%10.73 of 10 mg | 30 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-B04D4E | NAD+ | NJ03587 | 99.723% | 109.1%109.07 of 100 mg | 30 May 2026 | PASSrevised by the lab 2026-05-31, figures unchanged | Kovera ↗our verifier → |
| KVR-2026-AD8EE3 | MOTS-c | MS03581 | 99.967% | 114.1%11.41 of 10 mg | 30 May 2026 | PASSover 110% of labelrevised by the lab 2026-05-31, figures unchanged | Kovera ↗our verifier → |
| KVR-2026-912564 | GHK-Cu | CU04356 | 98.891% | 114.4%57.21 of 50 mg | 30 May 2026 | PASSover 110% of labelrevised by the lab 2026-05-31, figures unchanged | Kovera ↗our verifier → |
| KVR-2026-90364F | Retatrutide | RT08794 | 99.29% | 113.7%11.37 of 10 mg | 30 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-529C9B | Tirzepatide | TR07379 | 99.29% | 118.3%11.83 of 10 mg | 30 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-0DFF88 | CJC-1295 (No DAC)/Ipamorelin | CP03573 | 99.644% | 111.1%11.11 of 10 mg | 30 May 2026 | PASSover 110% of labelrevised by the lab 2026-05-31, figures unchanged | Kovera ↗our verifier → |